Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

2.76
Delayed Data
As of Jan 20
 +0.09 / +3.37%
Today’s Change
1.65
Today|||52-Week Range
6.37
+10.40%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baum Mark L
Chief Executive Officer
Buy12/19/2016200,000$1.72$344.0K+60.47%
Baum Mark L
Chief Executive Officer
Buy12/19/2016156,000$1.79$279.2K+60.47%
Lindstrom Richard L
Director
Buy12/19/2016100,000$1.79$179.0K+60.47%
Opaleye Management Inc
Buy3/11/201645,000$3.60$162.0K-31.68%
Baum Mark L
Chief Executive Officer
Sale12/19/201683,709$1.72$144.0K+60.47%
Boll Andrew R
Chief Financial Officer
Buy12/19/201639,000$1.79$69.8K+60.47%
Boll Andrew R
Chief Financial Officer
Buy2/01/201615,000$3.68$55.2K-50.80%